Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

ReachMD Launches CME iPhone APP
ReachMD, which provides medical news and information to healthcare practitioners, is raising its profile with the Continuing Medical Education, or CME, application for the Apple iPhone and iPod touch. This is the first CME application that lets users listen to all ReachMD Continuing Medical Education content, get regular updates on new Continuing Medical Education content and take Continuing Medical Education tests for credit, all from their iPhone or iPod touch.
generic viagra online
President Obama Picks New York City Health Commissioner Thomas Frieden For CDC Director
President Obama on Friday appointed New York City Health Commissioner Thomas Frieden as CDC director, according to Obama administration officials, the New York Times reports. According to the Times, Frieden, an infectious disease specialist, has "cut a high and sometimes contentious profile" in his seven years as health commissioner in New York City, during which time he has advocated for a smoking ban in restaurants and bars, made HIV testing part of routine medical exams and protected a program that distributes 35 million condoms a year. According to the Times, Frieden is expected to take office next month. The Times reports that he will "inherit a host of immediate and long-term problems," including questions surrounding a vaccine for the H1N1 influenza virus, also known as swine flu, health care reform and organizational issues at CDC.The Times reports that a potential advantage for Frieden is a positive relationship with likely FDA Commissioner Margaret Hamburg, who also was New York City health commissioner. Frieden would work with Hamburg to combat the H1N1 flu virus and to re-evaluate the U.S. food safety system (Harris/Hartocollis, New York Times, 5/15).
News of the day
Growing Midwestern Clinical Research Organization Selects OmniComm Systems To Provide EClinical Solutions For Phase IV Studies
OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical trials announced that a growing US Clinical Research Organization (CRO) has selected OmniComm to provide eClinical solutions in connection with two of the CRO"s Phase IV studies covering approximately 27 sites and more than 700 subjects. Additional details were not disclosed. Phase IV studies take place after a drug has been approved for marketing and are designed to provide broader experience in evaluating the safety and effectiveness of the new medicine in larger numbers of patients, subpopulations of patients, and to compare and/or combine it with other available treatments.
Oncology

Alzheimer's Society Comment On New Tau Tangle Research

Tau protein tangles are found in the brains of people with a range of neurodegenerative diseases, including Alzheimer"s. New research published in Nature Cell Biology suggests that tangle formation can be transferred from one type of trans genetic mouse line to another. The research was carried out using two different mouse lines, one generated specifically to express a mutated form of human tau known to cause tangles and disease, the other generated to express normal human tau. Ordinary (wild type) mice do not have a type of tau that can make tangles. More research is needed to understand the implications of these results. "The observation that tangle formation can be transferred from one type of trans genetic mouse line to another is certainly exciting and may change the way we think about tangle formation in diseases such as Alzheimer"s. However, the research was carried out using two different trans genetic mouse lines and we will need a lot more research before we understand the implications of these observations. There is still so much we do not understand about the changes in tau that lead to tangle formation in humans and, eventually, widespread brain cell death. Each new piece of knowledge helps build a better picture and takes us closer to the point where we can stop loss of brain tissue and dementia for good." Dr Susanne Sorensen Head of Research Alzheimer"s Society Reference: Clavaguera F et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nature Cell Biology, published online 7 June 2009 Notes - One in three people over 65 will die with dementia. - Alzheimer"s Society research shows that 700,000 people in the UK have a form of dementia, more than half have Alzheimer"s disease. In less than 20 years nearly a million people will be living with dementia. This will soar to 1.7 million people by 2051. - Alzheimer"s Society champions the rights of people living with dementia and the millions of people who care for them. - Alzheimer"s Society works in England, Wales and Northern Ireland. - Alzheimer"s Society needs to raise money to help people live well with dementia today and for research to find a cure for tomorrow. You can donate now by calling 0845 306 0898 or visiting http://www.alzheimers.org.uk Alzheimer"s Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009